amiodarone has been researched along with betadex in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, WD; Cushing, DJ; Gralinski, MR; Kowey, PR; Lipicky, RJ; Massey, BW | 1 |
| Adams, MP; Cooper, WD; Cushing, DJ; Kowey, PR; Lipicky, RJ; Zhang, B | 1 |
| Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
| Csabai, K; Fenyvesi, É; Malanga, M; Szemán, J; Szente, L | 1 |
| Agbaria, R; Beig, A; Dahan, A | 1 |
| Marceau, F; Parks, A | 1 |
| Chen, G; Ren, L; Wang, D | 1 |
| Aguirre, AD; Ahmed, MS; Hulsmans, M; Kohler, RH; Nahrendorf, M; Rodell, CB; Weissleder, R | 1 |
| Rhoden, CRB; Rolim, CMB; Rubenick, JB; Rubim, AM; Vendrame, LO; Zanella, I | 1 |
1 review(s) available for amiodarone and betadex
| Article | Year |
|---|---|
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |
1 trial(s) available for amiodarone and betadex
| Article | Year |
|---|---|
Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; beta-Cyclodextrins; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Prognosis; Reference Values; Young Adult | 2009 |
7 other study(ies) available for amiodarone and betadex
| Article | Year |
|---|---|
PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzyl Alcohol; beta-Cyclodextrins; Blood Pressure; Cardiac Output; Dogs; Excipients; Female; Glucose; Heart Rate; Hypotension; Infusions, Intravenous; Myocardial Contraction; Polysorbates; Solubility | 2009 |
Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power.
Topics: Amiodarone; beta-Cyclodextrins; Cholesterol; Chromatography, High Pressure Liquid; Fatty Acids; Furosemide; Isomerism; Magnetic Resonance Spectroscopy; Methylation; Solubility; Tamoxifen | 2014 |
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplay.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Permeability; Rats; Solubility | 2015 |
Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation.
Topics: Amiodarone; Anticholesteremic Agents; Autophagy; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chloroquine; Cholesterol; Cytostatic Agents; Cytotoxins; Human Umbilical Vein Endothelial Cells; Humans; Hydroxychloroquine; Lidocaine; Lovastatin; Lysosomes; Microtubule-Associated Proteins; Poly (ADP-Ribose) Polymerase-1; Procainamide; Quinacrine | 2016 |
Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State.
Topics: Amiodarone; Anti-Arrhythmia Agents; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Drug Compounding; Food-Drug Interactions; Freeze Drying; Humans; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
A Supramolecular Nanocarrier for Delivery of Amiodarone Anti-Arrhythmic Therapy to the Heart.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; beta-Cyclodextrins; Drug Carriers; Heart; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; RAW 264.7 Cells; Tissue Distribution | 2019 |
Formulation and characterization of amiodarone-methyl-beta-cyclodextrin inclusion complexes: A molecular modelling perspective.
Topics: Amiodarone; beta-Cyclodextrins; Models, Molecular; Solubility; Spectroscopy, Fourier Transform Infrared | 2024 |